a public good project by the
Synthesis
Company
of California

© 2026

Roberto Piva | doi.page

0 works0 citations0 h-index

Roberto Piva

University of Turin(IT)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Ubiquitin and proteasome pathways, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research, T-cell and Retrovirus Studies

Most-Cited Works

→ The anaplastic lymphoma kinase in the pathogenesis of cancer(2007)870 cited
→ Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma(2015)435 cited
→ Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death(2002)390 cited
→ Exercise training intervention after coronary angioplasty: the ETICA trial(2001)347 cited
→ CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib(2007)252 cited
→ NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors(2003)247 cited
→

Activation of the JNK/p38 Pathway Occurs in Diseases Characterized by Tau Protein Pathology and Is Related to Tau Phosphorylation But Not to Apoptosis

(2001)

174 cited

→ Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes(2006)164 cited

→ Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms(2010)161 cited

→ c-Jun, JNK/SAPK Kinase and Transcription Factor NF-κB Are Selectively Activated in Astrocytes, but not Motor Neurons, in Amyotrophic Lateral Sclerosis(1997)158 cited